About Sofosbuvir,Velpatasvir
            
            Class: | Antiviral (HCV NS5B polymerase inhibitor and NS5A inhibitor)  
Use: | Treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients 3 years of age and older, with or without cirrhosis, and in combination with ribavirin for certain genotypes.  
Adult dose: | One tablet (Sofosbuvir 400 mg / Velpatasvir 100 mg) taken orally once daily, with or without food, for 12 weeks.  
Pediatric dose: | For patients aged 3 years and older, the dosage is based on weight: 17 to 
         
        
            
                
                
                    
                        Drug Class
                    
                    Antiviral (HCV NS5B polymerase inhibitor and NS5A inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients 3 years of age and older, with or without cirrhosis, and in combination with ribavirin for certain genotypes.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F) in a tightly closed container, protected from moisture and light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Gilead Sciences International Ltd., UNITED KINGDOM
                    
                    
                    Package Size
                    28's HDPE Bottle
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 84714.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        One tablet (Sofosbuvir 400 mg / Velpatasvir 100 mg) taken orally once daily, with or without food, for 12 weeks.
                    
                    
                        Pediatric Dose
                    
                    
                        For patients aged 3 years and older, the dosage is based on weight: 17 to < 30 kg: 1 tablet daily; 30 kg to < 45 kg: 1.5 tablets daily; ≥ 45 kg: 1 tablet daily.
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, headache, nausea, insomnia, and diarrhea.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Co-administration with strong inducers of CYP3A (e.g., rifampin, St. John's wort) and in patients with a history of hypersensitivity to any component of the formulation.
         
        
        
            
                Important Warnings
            
            Risk of reactivation of hepatitis B in patients with a history of hepatitis B virus infection; monitor liver function tests during and after treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.